Technical Analysis for VSTM - Verastem, Inc.

Grade Last Price % Change Price Change
grade F 3.46 2.37% 0.08
VSTM closed up 2.37 percent on Friday, January 18, 2019, on 88 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical VSTM trend table...

Date Alert Name Type % Chg
Jan 18 Stochastic Reached Oversold Weakness 0.00%
Jan 18 Oversold Stochastic Weakness 0.00%
Jan 17 NR7 Range Contraction 2.37%
Jan 17 Doji - Bullish? Reversal 2.37%
Jan 16 20 DMA Resistance Bearish 2.37%
Jan 15 Doji - Bullish? Reversal 0.58%
Jan 14 Fell Below 20 DMA Bearish 1.47%
Jan 14 Wide Bands Range Expansion 1.47%
Jan 14 Down 3 Days in a Row Weakness 1.47%
Jan 11 Stochastic Sell Signal Bearish -6.99%

Older signals for VSTM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib testing in ovarian cancer, as well as developing for the treatment of mesothelioma and breast cancer. It is also developing FAK inhibitor VS-4718 and PI3K/mTOR inhibitor VS-5584 in patients with advanced cancers. The company's product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. Verastem, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Is VSTM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.35
52 Week Low 2.77
Average Volume 2,316,744
200-Day Moving Average 6.04
50-Day Moving Average 4.323
20-Day Moving Average 3.5715
10-Day Moving Average 3.695
Average True Range 0.284
ADX 29.21
+DI 16.8193
-DI 29.0205
Chandelier Exit (Long, 3 ATRs ) 3.398
Chandelier Exit (Short, 3 ATRs ) 3.992
Upper Bollinger Band 4.1022
Lower Bollinger Band 3.0408
Percent B (%b) 0.39
BandWidth 29.718606
MACD Line -0.2203
MACD Signal Line -0.2407
MACD Histogram 0.0204
Fundamentals Value
Market Cap 127.99 Million
Num Shares 37 Million
EPS -1.24
Price-to-Earnings (P/E) Ratio -2.79
Price-to-Sales 0.00
Price-to-Book 2.72
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.79
Resistance 3 (R3) 3.76 3.62 3.74
Resistance 2 (R2) 3.62 3.54 3.64 3.72
Resistance 1 (R1) 3.54 3.48 3.58 3.57 3.70
Pivot Point 3.40 3.40 3.42 3.42 3.40
Support 1 (S1) 3.32 3.32 3.36 3.35 3.22
Support 2 (S2) 3.18 3.26 3.20 3.20
Support 3 (S3) 3.10 3.18 3.19
Support 4 (S4) 3.13